In Vivo Binding of the Cry11Bb Toxin of Bacillus thuringiensis subsp. medellin to the Midgut of Mosquito Larvae (Diptera: Culicidae)
Mosquitoes are vectors of important tropical diseases such as malaria, yellow fever, and dengue. Control of mosquito vectors has been accomplished with bioinsecticides developed with the bacteria Bacillus thuringiensis subsp. israelensis and B. sphaericus. B. thuringiensis subsp. israelensis produces Cry4Aa, Cry4Ba, Cry10Aa, Cry11Aa, and Cyt1Aa toxins, while B. sphaericus produces a binary toxin. Resistance of several populations of Culex mosquitoes to B. sphaericus toxin in different regions of the world has been reported (Rao et al. 1995 , Regis et al. 1995 . Resistance to B. thuringiensis subsp. israelensis has not been reported in the field, although resistant mosquitoes populations have thus been selected in the laboratory (Georghiou & Wirth 1997 , Wirth et al. 1998 . For these reasons and due to the severe impact on public health of the diseases transmitted by mosquitoes, interest on identification of new strains, and active toxins against mosquitoes has increased resulting in the discovery of new toxins (Schnepf et al. 1998) . The Cry11Bb toxin produced by B. thuringiensis subsp. medellin is active against different species of mosquito larvae (Orduz et al. 1994 (Orduz et al. , 1998 , and could represent a new alternative for mosquito larvae control.
The Cry11Bb protein requires a proteolytic processing of the 94 kDa protoxin in order to produce the 30 and 35 kDa active fragments, through an intermediate 68 kDa carried-out by intestinal proteases of the target insect (Segura et al. 2000) . The mode of action of Cry proteins has been described based mainly on B. thuringiensis lepidopteran active toxins. The active fragments specifically interact with brush border membranes of the midgut's epithelial cells (Van Rie et al. 1990) , with the irreversible binding being fundamental for toxicity (Rajamohan & Charles 1995 , Abdul-Rauf & Ellar 1999 , Aronson & Shai 2001 . Later on in the process, pores are formed, that possibly require the intermolecular interaction among several monomers of the toxin (Aronson et al. 1999 , Soberon et al. 2000 . These pores alter the permeability of the membrane (Luo et al. 1999) , cause inhibition of amino acid transport (Parenti et al. 1995) , with cellular death occurring due to an osmotic lysis mechanism.
The analyses of the in vivo and in vitro binding of the Cry4Aa, Cry4Ba, and Cry11Aa B. thuringiensis subsp. israelensis toxins in the midgut of the An. gambiae larvae have shown that these toxins are located in the apical microvilli of the posterior midgut with a mild binding being observed in the anterior midgut, suggesting that in the posterior midgut are receptors present with higher affinity or at higher concentration (Ravoahangimalala et al. 1993 , Ravoahangimalala & Charles 1995 . The binding of the toxin to the apical microvilli of the midgut or to the midgut vesicles has generally been correlated with insect's susceptibility to the particular toxin, however, binding does not necessarily mean that the Cry protein is toxic (Ferré et al. 1991 , Bravo et al. 1992a , Feldman et al. 1995 (Segura 2001) .
In this study, we investigated the in vivo binding of the Cry11Bb toxin to the mosquito larvae midgut, through immunohistochemical methods in order to determine the primary site of action of this toxin.
MATERIALS AND METHODS
Insects -Larvae from the three mosquito species used (Ae. aegypti, An. albimanus, Cx. quinquefasciatus) and the lepidopteran Spodoptera frugiperda were maintained under laboratory conditions at 30 ± 2 o C under a 12:12 (light:dark) photoperiod in the insectary of the Corporación para Investigaciones Biológicas, Medellín, Colombia. Mosquitoes were fed with soybean powder. S. frugiperda was fed with an artificial diet based on bean (Arango et al. 2002) , and included as a negative control in which binding of Cry11Bb protein is not expected to occur.
Solubilization and purification of the Cry11Bb δ-endotoxin -The Cry11Bb protoxin was obtained from the acrystalliferous recombinant strain SPL-407 of B. thuringiensis subsp. thuriengiensis that had been transformed with the plasmid pSOB and contained a 3.1-kb insert of DNA encoding the Cry11Bb protoxin (Orduz et al. 1998 ). These cells were grown in 250 ml of M-one medium (Restrepo et al. 1997 ) supplemented with erythromycin (25 µg/ml) for 48 h at 30°C; and then transferred to a 20 l fermentor containing 10 l of culture medium; the fermentation conditions have already been published (Vallejo et al. 1999) . The final whole culture was harvested by centrifugation, the pellet was treated with 1 M NaCl for 1 h with shaking at 300 rpm, at 30°C; the salt was removed by washing twice in water supplemented with 10 mM of phenylmethylsulfonylflouride (PMSF) (Sigma) and 10 mM ethylenediaminetetraacetic acid (EDTA) at 4°C. The resulting pellet was treated with 1 M NaCl/1% Triton-X100 at 4°C, salt and detergent were removed with extensive washes by centrifugation at 9000 g for 15 min in distilled water supplemented with 1 mM PMSF and 100 mM EDTA at 4°C, and the pellet was resuspended in 50 ml of 50 mM cyclohexylaminopropane sulfonic acid (CAPS) pH 10.6/ 0.05% β-mercaptoethanol, and left in the shaker for 1 h at 37°C, at 300 rpm. The supernatant containing the soluble toxin was centrifuged at 15,000 g for 1 h at 4°C, and protein concentration was determined by the Bradford method with bovine serum albumin-BSA as standard (Bradford 1976) .
Purification of the Cry11Bb toxin was performed through ionic exchange chromatography in a fast performance liquid chromatograph (FPLC -Bio-Rad, BioLogic LP) using an anionic exchange column Econopack High Q (Bio-Rad), previously balanced with 50 mM CAPS, pH 10.6. The soluble protein (50 mg) was filtered through a 0.22 µm filter and applied to a 5 ml bed of a Q-sepharose column. The toxin was eluted from the column with a NaCl gradient from 0 to 1 M in 50 mM CAPS (pH 10.6) during 40 min. The collected fractions were analyzed through sodium dodecyl sulfate 10% polyacrilamide gel electrophoresis (SDS-PAGE), and fractions were finally aliquoted and stored at -20°C until used.
Cry11Bb treatments -Early fourth instars of the mosquito species under starvation for 20 h were treated with 21.5 µg/ml, which corresponded to approximately 500-fold the half lethal concentration for the mosquitoes for variable periods of time, 0.25, 0.5, 0.75, 1, and 2 h, this concentration had been previously used by Orduz et al. (1994) . When intoxication and mortality were observed, larvae were removed to a petri dish with distilled water to wash the toxin excess. Fifth instar S. frugiperda larvae were fed with a micro-syringe with 10 µl of Cry11Bb toxin solution containing 10 µg/ml while control larvae were treated with 10 µl of 1% BSA.
Preparation and sectioning of insect tissues -After exposure to the Cry11Bb treatments, mosquito larvae were placed in neutral formaldehyde. After feeding S. frugiperda larvae with the toxin, guts were dissected at 4°C and the midgut was fixed in neutral formaldehyde. Mosquito larvae and their midguts were dehydrated in increasing isopropyl alcohol concentrations, rinsed in xylol and included in paraffin. Five µm sections were obtained and placed in carriers loaded with 2% 3-aminopropyltriethoxy-silane (Bravo et al. 1992b) .
Antibodies -Mice polyclonal antibody against Cry11Bb (94 kDa) was prepared as indicated by Harlow and Lane (1999) . Sensibilization and specificity were evaluated by ELISA and Western blot with 1:100, 1:1000 dilutions, respectively, of the mice sera using standard techniques (Voller et al. 1980) . The immunodetection was performed in combination with a peroxidase-conjugated goat IgG fraction to mouse IgG (whole molecule) (ICN Pharmaceuticals, Eappel).
Immunohistochemical localization of the Cry11Bb toxin -Detection of Cry11Bb toxin was performed through modifications of the technique developed by Bravo et al. (1992b) . The sections were de-paraffinated in 100% xylol and hydrated in decreasing concentrations of ethanol, washed in distilled water and balanced in Tris buffer saline (TBS) (66 mM NaCl, 1.6 mM KCl, 25 mM Tris base, pH 7.4). Antigen unmasking was carried-out with 1 mg/ml of trypsin in 0.2 N HCl for 5 min at room temperature. Trypsin was inactivated by addition of 0.5 mM PMSF with incubation for 5 min and then the endogen peroxidase activity was blocked by incubating the tissue sections with 0.5% H 2 O 2 for 30 min and 6% H 2 O 2 for 15 min in methanol, at room temperature. The tissue section boundaries were marked with hydrophobic pencil (DAKO) in order to achieve uniformity in the incubations. The tissue samples were blocked with 3% BSA in TBS for 1 h at a room temperature, rinsed with TTBS (0.5% Triton-X100 TBS ), and incubated 1 h at 37°C in a humid chamber with 1:1000 of the polyclonal antibody raised in mouse against the Cry11Bb protein diluted in TBS with 1% BSA, incubated for 40 min a 37°C in humid chamber with 1:200 of peroxidase-conjugated goat IgG fraction to mouse IgG, and washed again with TBS. Color development was achieved with 3,3-diaminobenzidine (DAB) in chromogen solution in imidazole-HCl buffer pH 7.5 containing hydrogen peroxide and an antimicrobial agent (Liquid DAB large volume substrate-chromogen system DAKO) for 3 min at room temperature. The counterstaining of the tissue sections was performed with Harris hematoxilin for 10 s and ammoniacal water for 10 s; the tissues were dehydrated in increasing concentrations of ethanol and clarified in xylol; finally, the sections were covered with entellan (Merk) mounting resin and analyzed by light microscopy.
RESULTS
Polyclonal antibodies against Cry11Bb were able to detect the 94 kDa protoxin, the 68 kDa intermediate and the 35 kDa form of the Cry11Bb toxin -Production of polyclonal antibodies anti-Cry11Bb1 was assessed by ELISA, obtaining a titre of 3.56 (log 10 ). These polyclonal antibodies obtained in mice recognized the 94 kDa protoxin, as well as the products of the proteolytic processing, including the 68 kDa intermediate and the 35 kDa active fragment; however, the 30 kDa active fragment was only weakly recognized by Western blot (Fig. 1) .
Toxicological effects of the Cry11Bb toxin -In the treatments containing 21.5 µg/ml of Cry11Bb, approximately 500-fold the LC 50 of the Cry11Bb for Ae. aegypti, An. albimanus, and Cx. quinquefasciatus, mosquito larvae intoxication was observed 30 min after exposure to the toxin and mortality increased 30 min later on for Ae. aegypti and Cx. quinquefasciatus. The external toxicological symptoms were seen only 2 h after treatment in An. albimanus larvae. Toxic effects on S. frugiperda larvae were not observed after treatment with the Cry11Bb toxin.
Immunohistochemical localization of the Cry11Bb toxin on the apical microvilli of the midgut ephitelial cells -Binding of the Cry11Bb toxin to mosquito larvae tissues was observed after 15 min exposure to the Cry11Bb toxin by a brownish staining at the apical microvilli, with the staining intensity remaining unchanged from this time onwards. Control larvae not exposed to the Cry11Bb toxin or those in which the polyclonal antibody against Cry11Bb was omitted, did not show the brownish coloration (Figs  2A, D, G) in none of the mosquito species tested. The Cry11Bb toxin was also detected on the apical microvilli and in the basal membrane of the posterior midgut epithelium cells of Ae. aegypti, An. albimanus, and Cx. quinquefasciatus after 15 min exposure to the toxin (Figs 2B, E, H, respectively). In the gastric caeca of the three mosquito species, strong signals were also observed ( Figs  2C, F, I ), while in anterior midgut the signal was weak (data not shown).
Histopathological effects of the Cry11Bb toxin in mosquito larvae -The general histopathological changes induced by the Cry11Bb toxin in the mosquito larvae gut epithelia included vacuolization of the cytoplasm, hypertrophy of the epithelial cells and their nucleus, brush border membrane impairment, and disintegration of the cells. After 2 h exposure to the Cry11Bb toxin, vacuolization of the cytoplasm and swollen nuclei were observed (Fig. 3A) , midgut columnar cells of the mosquito larvae were elongated (Fig. 3B) , the cells were disrupted at the apical region with vesicle formation, lysis and leakage of cytoplasm material into the gut lumen ( Figs 3B, C) . Additionally, in Ae. aegypti and An. albimanus larvae, the Cry11Bb toxin was detected in the Malpighian tubules 15 and 45 min after treatment with the toxin, respectively, while in Cx. quinquefasciatus larvae, the Cry11Bb toxin was only detected in the Malpighian tubule microvilli junctions 1 h after treatment, and 1 h later these structures had shrunken (Fig. 3D) .
Cry11Bb protein was detected in a diffuse way inside the cells and in the apical and basal parts of S. frugiperda gut epithelium (Fig. 4B) , in spite of the faint binding, the midgut of S. frugiperda cells had no histopathological changes (Fig. 4B) .
DISCUSSION
Present in vivo experiments showed that the Cry11Bb toxin bound preferentially to the posterior midgut apical microvilli and the gastric caeca of the evaluated mosquito species; and therefore, the epithelial cells of the midgut could be considered as the main target of this toxin. The Cry11Bb toxin preferred localization in gastric caeca and the posterior midgut of mosquito larvae may be due to a higher concentration of receptor molecules or of molecules with higher binding affinity. Differential binding in the anterior and posterior midgut of dipterans has already been observed in mosquito larvae treated with B. thuringiensis or B. sphaericus toxins (Ravoahangimalala et al. 1993 , Ravoahangimalala & Charles 1995 . Toxicological effects of the Cry11Bb toxin in mosquito larvae were in agreement with the data reported by Orduz et al. (1994) .
The immunolocalization of the Cry11Bb toxin observed in the basal membrane of Ae. aegypti and An. albimanus larvae was possibly due to the toxin's leakage or at least part of it from the midgut lumen to the basal area of the epithelium after disruption of the cellular integrity of the midgut tissue. The deterioration of the intercellular junc- tions could be a consequence of the damage caused by the Cry11Bb toxin at the cellular membrane level, as this situation has also been observed in Heliothis virescens midgut after 3 h exposure to the Cry1Ac (Forcada et al. 1999) .
Additionally, the Cry11Bb toxin was observed in Cx. quinquefasciatus larval midgut 15 min after treatment, and 1 h after exposure to the toxin on the apical microvilli of the Malpighian tubules. It is unknown if the binding of the Cry11Bb toxin to the Malpighian tubules contributes to mortality of mosquito larvae. The binding sites of several Cry toxins have been located on the Malpighian tubule epithelium of some insect species; however, their role in toxicity has not been fully characterized. Although Maddrell et al. (1989) reported important changes in the trans-epithelial potential difference of Rhodnius prolixus Malpighian tubules after treatment with B. thuringiensis toxin and Reisner et al. (1989) located B. thuringiensis kurstaki δ-endotoxins on the Malpighian tubules of Calpodes ethlius larvae and described its effect as inhibitory of fluid secretion causing cytological alterations, which ended-up in cellular lysis and epithelial damage, Denolf et al. (1993) reported binding of Cry1Ab1, Cry1Ac1, and Cry1Ba1 toxins to the Malpighian tubules of Ostrinia nubilalis, but did not suggest a relevant role in the mortality of this lepidopteran. It is possible that the damage caused by the Cry11Bb toxin in the mosquito larvae midgut intercellular junctions, as seen in Fig. 3B , could have permitted toxin leakage into the hemolymph to reach the Malpighian tubules, producing shrinking of their epithelium (Fig. 3D) , and perhaps impairing their osmoregulatory functions before larval death.
Although S. frugiperda was not susceptible to the toxin, the weak localization of the Cry11Bb protein in its midgut, could be the result of non-specific binging or to low affinity binding to a putative receptor with some degree of homology to the mosquito larvae receptors. However, this binding does not guarantee toxicity (Ferré et al. 1991 , Bravo et al. 1992a , Feldman et al. 1995 .
Some studies have suggested that Cry1 toxins could have more than one binding site in Heliothis sp., Spodoptera sp., and Manduca sexta (Oddu et al. 1993 , Masson et al. 1995 . It is assumed that the mode of action of the Cry11 toxins is similar to that of Cry1 toxins; therefore, it is possible that the Cry11Bb toxin could have more than one receptor in the midgut apical microvilli of the mosquitoes evaluated as it has been suggested by Segura (2001) . (Segura 2001) . The in vivo binding of Cry11Bb to the apical microvilli of mosquito larvae, probably corresponds to the 68 kDa form, since the 94 kDa protoxin disappears in the midgut lumen 10 min after treating the larvae (Segura et al. 2000) , and the binding pattern seen as the brownish staining was similar in all the analyzed times of the present study.
The information obtained by immunohistochemical techniques indicates that the midgut is the primary site for the action of the Cry11Bb toxin, being preferentially localized in gastric caeca and the posterior midgut. More-over, the Cry11Bb toxin was localized in the Malphigian tubules of Ae. aegypti An. albimanus, and Cx. quinquefasciatus larvae, which may indicate a possible relationship with the mode of action of this toxin. Further research that includes in vivo or in vitro homologous and heterologous competition assays will permit to know if the Cry11Aa and Cry11Bb toxins share a common receptor. This type of research will contribute to the design of more effective biological control agents.
